Physician

Charles L Brooks, M.D.

According to 2025 Medicare claims, Charles Brooks, M.D. (NPI: 1770532517) practices gastroenterology in the Lawrence, KS market, with the plurality of this provider's patient population coming from Douglas, KS. This provider's primary affiliated billing organization is LAWRENCE PHYSICIANS LLC (NPI: 1952718173; TIN: 471216616) and primary practice location at 66044-1360.

Brooks' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 747 traditional Medicare patients, billed 1,287 HCPCS/CPT codes, and received $146,367 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 318 prescription claims across 116 beneficiaries totaling $61,673 in drug costs, led by Xifaxan (Rifaximin). Open Payments data shows 16 records totaling $376. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $30,313 to $61,673. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$83K$165K2015 Medicare payment: $142,925 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $148,427 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $151,887 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $165,166 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $132,427 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $127,113 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $113,850 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $162,826 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $127,929 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $146,367 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155581,419$142,925
20165551,382$148,427
20176241,550$151,887
20186041,536$165,166
20195551,289$132,427
20205391,335$127,113
20215071,101$113,850
20227651,413$162,826
20236201,121$127,929
20247471,287$146,367

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$138K$276K2015 Drug cost: $30,313 (USD; Tot_Drug_Cst)2016 Drug cost: $30,006 (USD; Tot_Drug_Cst)2017 Drug cost: $59,518 (USD; Tot_Drug_Cst)2018 Drug cost: $126,483 (USD; Tot_Drug_Cst)2019 Drug cost: $140,826 (USD; Tot_Drug_Cst)2020 Drug cost: $86,678 (USD; Tot_Drug_Cst)2021 Drug cost: $77,170 (USD; Tot_Drug_Cst)2022 Drug cost: $176,383 (USD; Tot_Drug_Cst)2023 Drug cost: $276,206 (USD; Tot_Drug_Cst)2024 Drug cost: $61,673 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201598308$30,313
201695282$30,006
2017144482$59,518
2018145568$126,483
2019149564$140,826
2020166634$86,678
2021141495$77,170
2022146449$176,383
2023122362$276,206
2024116318$61,673

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare265266$181
G0105Colorectal cancer screening; colonoscopy on individual at high risk7878$166
45380Biopsy of large bowel using a flexible endoscope8484$97
43239Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope293305$72
43450Dilation of esophagus129137$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XifaxanRifaximin13390$43,206
UrsodiolUrsodiol11494$2,731
Budesonide DrBudesonide21882$2,219
FamotidineFamotidine432,958$760
OmeprazoleOmeprazole794,514$747

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$376ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Charles L. Brooks, M.D.?

Tedicare shows public-source Medicare data for Charles L. Brooks, M.D. (NPI 1770532517), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles L. Brooks, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles L. Brooks, M.D.?

Charles L. Brooks, M.D. is linked to LAWRENCE PHYSICIANS LLC (billing NPI 1952718173) in the available physician profile data.

Does Charles L. Brooks, M.D. have Open Payments data?

Charles L. Brooks, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.